[Lectin-related use of mistletoe: an experimental form of treatment with preclinically demonstrated potential risks]

Dtsch Med Wochenschr. 2002 Mar 1;127(9):457-9. doi: 10.1055/s-2002-20425.
[Article in German]
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adjuvants, Immunologic / adverse effects
  • Adjuvants, Immunologic / pharmacology
  • Adjuvants, Immunologic / therapeutic use*
  • Animals
  • Humans
  • Lectins / adverse effects
  • Lectins / pharmacology
  • Lectins / therapeutic use*
  • Mice
  • Mice, Inbred C3H
  • Mistletoe* / adverse effects
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Phytotherapy* / adverse effects
  • Plant Lectins
  • Plant Preparations*
  • Plant Proteins*
  • Rats
  • Ribosome Inactivating Proteins, Type 2
  • Risk Factors
  • Toxins, Biological / adverse effects
  • Toxins, Biological / pharmacology
  • Toxins, Biological / therapeutic use*
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / pathology

Substances

  • Adjuvants, Immunologic
  • Lectins
  • Plant Lectins
  • Plant Preparations
  • Plant Proteins
  • Ribosome Inactivating Proteins, Type 2
  • Toxins, Biological
  • ribosome inactivating protein, Viscum